EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate

Published:2024-10 Issue: Volume:374 Page:171-180
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Bibbò Sandra,Capone Emily,Lovato Giulio,Ponziani Sara,Lamolinara Alessia,Iezzi Manuela,Lattanzio Rossano,Mazzocco Katia,Morini Martina,Giansanti Francesco,De Laurenzi Vincenzo,Whitfield Jonathan,Iacobelli Stefano,Ippoliti Rodolfo,Beaulieu Marie-Eve,Soucek Laura,Sala Arturo,Sala Gianluca

Publisher

Elsevier BV

Reference34 articles.

1. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion;Dhanasekaran;Nat. Rev. Clin. Oncol.,2022

2. An overview of MYC and its interactome;Conacci-Sorrell;Cold Spring Harb. Perspect. Med.,2014

3. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma;Zeid;Nat. Genet.,2018

4. Blocking Myc to treat Cancer: reflecting on two decades of Omomyc;Masso-Valles;Cells,2020

5. Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy;Beaulieu;Sci. Transl. Med.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP